4.6 Article

Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis

Journal

EXPERT OPINION ON DRUG DELIVERY
Volume 11, Issue 8, Pages 1163-1181

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1517/17425247.2014.917076

Keywords

central composite design; curcumin; nanoparticles; optimization; response surface methodology; visceral leishmaniasis

Funding

  1. University Grant Commission (UGC), New Delhi

Ask authors/readers for more resources

Objective: The study aims at formulation and optimization of macrophage-targeted curcumin-loaded mannosylated chitosan nanoparticles (Cur-MCNPs) of curcumin (CUR) to improve its therapeutic potential in the treatment of visceral leishmaniasis (VL). Methods: Response surface methodology (RSM) using central composite design was employed to study the effect of formulation factors on physicochemical-dependent characteristics. Chitosan was coupled with D-mannose, by reductive amination, to prepare a mannosylated chitosan, a conjugate polymer and a subsequent formulation of Cur-MCNPs. Optimized formulation prepared using RSM was evaluated for in vitro release kinetics at physiological pH 7.4 and endosomal macrophage pH 4.5; in vivo pharmacokinetic profile and targeting potential were evaluated by fluorescence microscopy. Results: Optimized Cur-MCNPs exhibited spherical and smooth surface with a mean particle size of 215 nm, polydispersity index of 0.381, zeta potential of + 24.37 mV and % entrapment efficiency of 82.12%. The pharmacokinetic study of optimized Cur-MCNPs showed significant improvement in the value of mean resident time (39.38 h) compared to free CUR solution (0.30 h) (p < 0.05). In vivo uptake study indicated that endocytosis took place effectively within the macrophages of reticuloendothelial system. Conclusions: Thus, Cur-MCNPs could be considered as a promising delivery strategy towards active targeting of CUR to macrophages for the effective treatment of VL.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Chemistry, Medicinal

Formulation, optimization, hemocompatibility and pharmacokinetic evaluation of PLGA nanoparticles containing paclitaxel

Pooja Mittal, Harsh Vardhan, Gufran Ajmal, Gunjan Vasant Bonde, Ramit Kapoor, Ashu Mittal, Brahmeshwar Mishra

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2019)

Article Pharmacology & Pharmacy

Formulation and characterization of fast dissolving oral films containing buspirone hydrochloride nanoparticles using design of experiment

Kanchan Bharti, Pooja Mittal, Brahmeshwar Mishra

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2019)

Article Biotechnology & Applied Microbiology

Gold nanoparticles for sustained antileukemia drug release: development, optimization and evaluation by quality-by-design approach

Sandeep Kumar Reddy Adena, Mansi Upadhyay, Harsh Vardhan, Brahmeshwar Mishra

NANOMEDICINE (2019)

Article Biotechnology & Applied Microbiology

Ciprofloxacin HCl and quercetin functionalized electrospun nanofiber membrane: fabrication and its evaluation in full thickness wound healing

Gufran Ajmal, Gunjan Vasant Bonde, Sathish Thokala, Pooja Mittal, Gayasuddin Khan, Juhi Singh, Vivek Kumar Pandey, Brahmeshwar Mishra

ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)

Article Materials Science, Biomaterials

Locust bean gum and sodium alginate based interpenetrating polymeric network microbeads encapsulating Capecitabine: Improved pharmacokinetics, cytotoxicity &in vivo antitumor activity

Mansi Upadhyay, Sandeep Kumar Reddy Adena, Harsh Vardhan, Sarita K. Yadav, Brahmeshwar Mishra

MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2019)

Review Oncology

A Critical Review on Anticancer Mechanisms of Natural Flavonoid Puerarin

Manikanta Murahari, Vikas Singh, Pramila Chaubey, Vasanti Suvarna

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2020)

Article Biophysics

Assessing the viability of Soluplus® self-assembled nanocolloids for sustained delivery of highly hydrophobic lapatinib (anticancer agent): Optimisation and in-vitro characterisation

Gunjan Vasant Bonde, Gufran Ajmal, Sarita Kumari Yadav, Pooja Mittal, Juhi Singh, Bharati V. Bakde, Brahmeshwar Mishra

COLLOIDS AND SURFACES B-BIOINTERFACES (2020)

Review Pharmacology & Pharmacy

Targeted drug nanocrystals for pulmonary delivery: a potential strategy for lung cancer therapy

Manish Kumar, Abhishek Jha, Madhu, Brahmeshwar Mishra

EXPERT OPINION ON DRUG DELIVERY (2020)

Review Pharmacology & Pharmacy

Electrospun nanofiber-based drug delivery platform: advances in diabetic foot ulcer management

D. R. Madhukiran, Abhishek Jha, Manish Kumar, Gufran Ajmal, Gunjan Vasant Bonde, Brahmeshwar Mishra

Summary: Electrospinning is a convenient method for fabricating nanofibers, with great potential in delivering drugs or therapeutic molecules to wound sites, especially in the treatment of diabetic foot ulcers. This review discusses the evolution of electrospinning techniques, various types of electrospun nanofibers used for DFU or chronic diabetic wounds, challenges in nanofiber preparation, and methods for evaluating their efficacy in diabetic wound healing. Expert opinions suggest that electrospinning-based nanofibers are safe, effective, and multifunctional for managing DFUs.

EXPERT OPINION ON DRUG DELIVERY (2021)

Review Pharmacology & Pharmacy

A Review on Screening Models for Potential Therapeutic Candidates and Targets Against SARS-CoV-2

Mohana Das, Manish Kumar, Abhishek Jha, D. R. Madhukiran, Kanchan Bharti, Shomedeep Mondal, Brahmeshwar Mishra

Summary: Coronaviruses are a group of RNA viruses that primarily infect the respiratory system. Recent outbreaks of Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome Coronaviruses have highlighted the urgent need for new screening models to identify potential drugs against COVID-19. The global spread of the SARS-CoV-2 virus has led to a massive pandemic with no successful treatment currently available.

CURRENT DRUG TARGETS (2021)

Review Immunology

Emerging advances in cationic liposomal cancer nanovaccines: opportunities and challenges

Mohammad Z. Ahmad, Javed Ahmad, Mohammed Y. Alasmary, Basel A. Abdel-Wahab, Musarrat H. Warsi, Anzarul Haque, Pramila Chaubey

Summary: The advancements in cancer therapeutics have seen a recent surge in the use of liposomes, particularly cationic liposomes, as a promising vaccine delivery platform for cancer immunotherapy. Physicochemical characteristics of liposomes and their components play a significant role in modulating the immune response, making them effective in promoting cancer immunotherapy.

IMMUNOTHERAPY (2021)

Article Instruments & Instrumentation

Mannose-conjugated chitosan nanoparticles for delivery of Rifampicin to Osteoarticular tuberculosis

Pratiksha Prabhu, Trinette Fernandes, Pramila Chaubey, Parvinder Kaur, Shridhar Narayanan, Ramya Vk, Sujata P. Sawarkar

Summary: Tuberculosis is a potentially fatal contagious disease and osteoarticular TB treatment using standard regimen of anti-tubercular drugs faces challenges such as poor patient compliance, long treatment period, and toxicity. Nanotherapeutics, specifically polymeric nanoparticles, offer an ideal approach for targeting macrophages containing mycobacteria. By conjugating nanoparticles with ligands, such as mannose, uptake by macrophages can be improved. Incorporating these nanoparticles into an in situ gelling system shows promise in improving drug release and localization in the intra-articular cavity.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2021)

Review Biotechnology & Applied Microbiology

Advances in lipid-based pulmonary nanomedicine for the management of inflammatory lung disorders

Manish Kumar, Abhishek Jha, Kanchan Bharti, Gourav Parmar, Brahmeshwar Mishra

Summary: Inflammatory lung disorders, such as chronic obstructive pulmonary disease, asthma, and pulmonary fibrosis, are a growing global health concern. The current therapeutic strategies and drugs used to manage these disorders face limitations. This review discusses the potential of lipid-based pulmonary nanomedicine as a platform to overcome these limitations and ensure targeted drug delivery with minimal side effects.

NANOMEDICINE (2022)

Article Pharmacology & Pharmacy

Development and Evaluation of Amorphous Solid Dispersion of Riluzole with PBPK Model to Simulate the Pharmacokinetic Profile

Kanchan Bharti, Deepika Deepika, Manish Kumar, Abhishek Jha, Vinod Tiwari, Vikas Kumar, Brahmeshwar Mishra

Summary: In this study, polymers were screened to produce a stable amorphous solid dispersion (ASD) of a poorly water-soluble drug Riluzole (RLZ). Polyacrylic acid (PAA) was selected due to its strong drug-polymer interaction and wetting property. Experimental data and a physiologically based pharmacokinetic (PBPK) model showed that the RLZ:PAA ASD significantly enhanced drug concentration in the brain, suggesting improved biopharmaceutical performance and therapeutic efficacy.

AAPS PHARMSCITECH (2023)

Review Multidisciplinary Sciences

Treatment of H. pylori infection and gastric ulcer: Need for novel Pharmaceutical formulation

Ashutosh Gupta, Shiran Shetty, Srinivas Mutalik, H. Raghu Chandrashekar, K. Nandakumar, Elizabeth Mary Mathew, Abhishek Jha, Brahmeshwar Mishra, Siddheesh Rajpurohit, Gundawar Ravi, Moumita Saha, Sudheer Moorkoth

Summary: This article introduces the background and treatment methods of peptic ulcer disease, with a focus on the challenges of H. pylori infection treatment and the current limitations. The article discusses novel formulation strategies such as extended-release drug delivery systems and nanoformulations to overcome the current bioavailability challenges, and proposes an innovative strategy to improve H. pylori eradication efficiency.

HELIYON (2023)

No Data Available